Mitosol 0.2 MG kits
Ended Awarded
- Contract number
- SPE2DB26FU7JQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,737
Award facts
- Contract value 100% obligated
- $19,737.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,737.00 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for MITOSOL 0.2 MG kits. The award, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, was issued without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract vehicle awarded November 13, 2025, that positions the company as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy supporting Department of Defense healthcare operations.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with substantial contracting activity through the Defense Logistics Agency's Medical Supply Chain division. The company's comprehensive product portfolio includes branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals serving military healthcare facilities worldwide. As a small business prime vendor contractor, DMS Pharmaceutical Group leverages its established performance on numerous delivery orders to fulfill the diverse and specialized pharmaceutical requirements of the federal military medical system across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DB26FU7JQ?
SPE2DB26FU7JQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 16, 2025.
How much is contract SPE2DB26FU7JQ worth?
The government has obligated $19,737 on SPE2DB26FU7JQ.
Is contract SPE2DB26FU7JQ an order under another contract?
Yes. SPE2DB26FU7JQ is a delivery order under SPE2DB22D9101, an indefinite delivery contract.
Was contract SPE2DB26FU7JQ competed?
The extent of competition for SPE2DB26FU7JQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award